To include your compound in the COVID-19 Resource Center, submit it here.

EPO revokes foundational Broad CRISPR patent

The European Patent Office revoked the Broad Institute of MIT and Harvard's foundational CRISPR patent on Wednesday, citing a lack of novelty over prior art. The decision could also affect several other European patents filed by the Broad Institute, which said it plans to appeal the decision.

In an

Read the full 487 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE